---
layout: post
title: "赛隆药业：注射用帕瑞昔布钠获得药品补充申请批准"
date: 2022-01-18 15:43:16 +0800
categories: cailianshe
tags: 财联社新闻
---
<p style="display:none;height:1px;overflow:hidden;"><br /></p><!-- EM_StockImg_Start --><p style="text-align:center;"><a href="http://quote.eastmoney.com/unify/r/0.002898" data-code="002898|0|2" data-code2="002898|0|6|" class="EmImageRemark" target="_blank"><img src="https://webquoteklinepic.eastmoney.com/GetPic.aspx?nid=0.002898&imageType=k&token=28dfeb41d35cc81d84b4664d7c23c49f&at=1" border="0" alt="K图 002898_0" data-code="K 002898|0|2" data-code2="K 002898|0|6|" style="border:#d1d1d1 1px solid;" width="578" height="276" /></a></p><!-- EM_StockImg_End --><p>赛隆药业公告，全资子公司注射用帕瑞昔布钠获得《药品补充申请批准通知书》。注射用帕瑞昔布钠的主要适应症为用于手术后疼痛的短期治疗。<br /></p><p class="em_media">（文章来源：财联社）</p>

<http://finews.zning.xyz/html_News/NewsShare.html?infoCode=NW202201182251978590>

[返回财联社新闻](//finews.withounder.com/category/cailianshe.html)｜[返回首页](//finews.withounder.com/)